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Abstract
Background: In common with many South East Asian countries, Malaysia is endemic for dengue. Dengue control
in Malaysia is currently based on reactive vector management within 24 h of a dengue case being reported.
Preventive rather than reactive vector control approaches, with combined interventions, are expected to improve
the cost-effectiveness of dengue control programs. The principal objective of this cluster randomized controlled
trial is to quantify the effectiveness of a preventive integrated vector management (IVM) strategy on the incidence
of dengue as compared to routine vector control efforts.
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Methods: The trial is conducted in randomly allocated clusters of low- and medium-cost housing located in the
Federal Territory of Kuala Lumpur and Putrajaya. The IVM approach combines: targeted outdoor residual spraying
with K-Othrine Polyzone, deployment of mosquito traps as auto-dissemination devices, and community
engagement activities. The trial includes 300 clusters randomly allocated in a 1:1 ratio. The clusters receive either
the preventive IVM in addition to the routine vector control activities or the routine vector control activities only.
Epidemiological data from monthly confirmed dengue cases during the study period will be obtained from the
Vector Borne Disease Sector, Malaysian Ministry of Health e-Dengue surveillance system. Entomological surveillance
data will be collected in 12 clusters randomly selected from each arm.
To measure the effectiveness of the IVM approach on dengue incidence, a negative binomial regression model will
be used to compare the incidence between control and intervention clusters. To quantify the effect of the
interventions on the main entomological outcome, ovitrap index, a modified ordinary least squares regression
model using a robust standard error estimator will be used.
Discussion: Considering the ongoing expansion of dengue burden in Malaysia, setting up proactive control
strategies is critical. Despite some limitations of the trial such as the use of passive surveillance to identify cases, the
results will be informative for a better understanding of effectiveness of proactive IVM approach in the control of
dengue. Evidence from this trial may help justify investment in preventive IVM approaches as preferred to reactive
case management strategies.
Trial registration: ISRCTN ISRCTN81915073. Retrospectively registered on 17 April 2020.
Keywords: Aedes, Dengue, Malaysia, Epidemiology, Cluster Randomized, Vector control, Autodissemination, outdoor
residual spray
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Background
Dengue fever, caused by one of the four dengue virus
serotypes (DENV1-DENV4), is a mosquito-borne disease
of public health importance due to its increasing burden
worldwide [1]. With 390 million estimated infections and
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10,000 deaths per year, dengue is the predominant
mosquito-borne virus in humans [2]. The threat of a pos-
sible dengue outbreak due to the introduction of dengue
virus by viremic travellers into areas where Aedes albopic-
tus mosquitoes have become established is also of con-
cern. Global warming may further exacerbate this
situation by enabling greater spread and transmission in
more temperate regions of the world such as Europe [1].
In Malaysia, Aedes aegypti and Aedes albopictus are the
primary and secondary mosquito species responsible for
dengue transmission [3]. The incidence of dengue in
Malaysia increased from 31.6 reported cases per 100,000
inhabitants in the year 2000 to 159.7 in 2010 [4] and to
396.4 per 100,000 inhabitants in 2015 [5]. In 2010, the
country spent an estimated US$73.5 million (95% confi-
dence interval CI = US$62.0–US$86.3 million) on the na-
tional dengue vector control programme [6]. The control
of dengue in Malaysia is based on rapid reactive vector
management within 24 h of a dengue case being reported.
The programme consists of space spray, source reduction,
and larviciding. Space spray has however a relatively short
life span compared to residual spraying [7, 8], and re-
peated use in a non-targeted application increases the po-
tential of mosquitoes to develop resistance.
Vector control has been shown to be highly effective in
reducing the density of Aedes populations [9], but there is
limited evidence of its efficacy in reducing the incidence
of Aedes-borne diseases [10, 11]. Designing more effective
and preventive rather than reactive vector control
programmes with combined interventions could be a key
solution in dengue prevention and control. In the absence
of an effective dengue vaccine, the World Health
Organization (WHO) calls for locally adapted and
sustainable integrated vector management (IVM) [12, 13].
The study protocol presented here is a cluster
randomized controlled trial (cRCT) based on proactive
IVM that combines three components: (1) targeted
outdoor residual spraying (TORS) with K-Othrine Poly-
zone (Bayer SAS), (2) deployment of mosquito traps as
auto-dissemination devices (ADDs, In2Care® Mosquito
Traps, In2Care B.V., The Netherlands), and (3) commu-
nity engagement (CE) activities.
K-Othrine® Polyzone, with deltamethrin as its active
ingredient (62.5 g/L), has been approved for use by the
WHO [14] and prequalified as vector control product
(PQT-VC reference 008-004).
Auto-dissemination devices are black plastic
containers that mimic breeding sites for female
mosquitoes [15]. These user-friendly control devices tar-
get cryptic, hard to find breeding sites and facilitate
precision-targeted larval control and continuous breed-
ing suppression of vector populations [15, 16].
Previous field evaluation of TORS and ADDs showed
effective reduction of the mosquito population [3, 17]. In
addition, the combination of insecticides with different
modes of action in the same programme is likely to limit
insecticide resistance in the local Aedes vector
population. However, to the best of our knowledge, the
combination of these components has not yet been
tested in a large trial with dengue incidence as the
primary endpoint.
Local communities are key actors in vector control
programmes and their engagement is essential for success
and sustainability of such programmes [18–20]. We expect
that community engagement by proactive communication
and information-sharing with the population of the study
areas will increase their adherence to operational proce-
dures, thus enhancing the efficacy of the proposed com-
bined vector control tools to promote favourable outcomes
with respect to decreased dengue incidence.
Objectives
The principal objective of this cRCT trial is to quantify
the effectiveness of a preventive IVM strategy combining
TORS, deployment of ADDs, and CE activities on the
incidence of dengue in randomly selected areas in the
Federal Territory of Kuala Lumpur and Putrajaya
(Malaysia) as compared to routine vector control efforts.
The secondary objective is to evaluate the effectiveness
of the IVM approach on the population density of Aedes
mosquitoes.
Trial design
The study is a non-blinded superiority cRCT conducted
in selected areas of the Federal Territory of Kuala Lum-
pur and Putrajaya, Malaysia. The trial protocol was reg-
istered with the ISRCTN registry on 17 April 2020 as
ISRCTN81915073.
For the purpose of the trial, a cluster is defined as a
locality, i.e. one residential area composed of
neighbouring buildings that share the same facilities
such as parking lots, food court, groceries store,
playground, and community halls.
The trial includes 300 clusters (mean number of
buildings per clusters = 4) which were randomly
allocated in a 1:1 ratio, to receive either the proactive
IVM in addition to the routine vector control activities
or the routine vector control activities only (see the
“Interventions” section for more details). The overall
population size in the control and intervention arms are
both estimated around 432.000 individuals.
Methods
Study setting
The trial is conducted in selected clusters of low- and
medium-cost housing located in the Federal Territory of
Kuala Lumpur and Putrajaya, Malaysia (Fig. 1). The def-
inition of low and medium cost is based on the average
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price of an apartment in a given area. Low-cost building
is defined as a flat/apartment with the price of less than
60 K€ while the price of medium-cost housing is more
than 60 K€ but less than 100 K€. Kuala Lumpur covers
243km2 (94 square miles) and had an estimated popula-
tion of 1.77 million in 2020. Putrajaya covers 49 km2
(18.9 square miles) and had an estimated population of
0.10 million in 2020.
Localities (clusters) in the Federal Territory of Kuala
Lumpur and Putrajaya with recurrent dengue outbreaks
reported from 2015 to 2018 were eligible (n = 895). We
excluded localities with missing data on the population (n
= 102), localities within a 1 km radius of an ongoing study
with Wolbachia (n = 3), high-cost localities (n = 246), and
localities with less than 1000, or more than 8000 inhabi-
tants (n = 215). Of the remaining 329 localities, 300 with
the highest incidence rates in 2015–2016 were retained for
the trial. Eligibility criteria for a dengue case to be registered
in the e-Dengue surveillance system is provided (Additional
file 1). Only confirmed dengue cases will be included (see
the “Outcomes” section).
Interventions
The study flowchart for selection and randomization
of eligible clusters is shown in Fig. 2. Clusters
(localities) randomly selected to the intervention arm
will receive the proactive IVM strategy, i.e. TORS,
deployment of ADDs (performed by the staff of a
pest control organisation hired for the purpose of
the trial), and active community engagement.
Routine dengue prevention and control measures are
under the responsibility of the Malaysian Ministry of
Health and should be maintained in both control
and intervention clusters as per Standard
Operational Procedures and guidelines given by the
Malaysian Ministry of Health. This programme
consists of health education, space spray (thermal
fogging and ultra-low volume space spray), source
reduction, and larviciding within 24 h a dengue case
is being reported. All information on the routine in-
secticide and technical information (date, extent of
activity, place, etc.) is recorded and described in trial
reports.
Fig. 1 Map of the study areas: Federal Territory of Kuala Lumpur and Putrajaya
Saadatian-Elahi et al. Trials          (2021) 22:374 Page 4 of 16
The trial will run for 2 years and the time schedule of
enrolment, intervention and data monitoring activities is
shown in Table 1.
Targeted outdoor residual spraying
K-Othrine Polyzone is a polymer enhanced suspension
concentrate aqueous formulation which has low odour
and high level of safety. The polymer technology used in
this formulation protects the active ingredients from
weather conditions, rainfall, and mechanical abruption
and ensures they remain available on treated surfaces for
up to 3 months, thereby reducing environmental
contamination. The insecticide dosage is 25 mg/m2 and
is applied by trained operators using a residual hand
compression sprayer (Semco, Japan). The target spray
areas are outer walls covered or partly covered
(corridors, staircase, parking, lobby or any corner liable
to become a resting spot for mosquitoes) in all floors.
We exclude sections of wall close to power plugs,
elevator buttons, walls covered with wall paper, oil-
based painted walls, or tiles. Residents are requested to
remove edible plants, hanging clothes, pet cages (e.g.
cats, dogs and birds), and to cover aquaria during the
day of the intervention. Parts of corridors with such ob-
jects are not sprayed. Based on our previous findings
showing the residual bio-efficacy of K-Othrine® Polyzone
for 16 weeks [17, 21], TORS is conducted every 4
months in all premises in al intervention areas.
To control the quality of TORS spraying, each spray
pump is equipped with a control flow valve. The latter is
a device that fits next to the nozzle and ensures that
output remains constant as the pressure in the spray
tank decreases. The spray pumps are washed after each
use to avoid clotting of the insecticide in the nozzles. All
spray cans are washed thoroughly, checked, and
calibrated once a week. During spraying activities, a
quality control officer observes the spraying procedure
and technique. Pictures and video recorded randomly by
the officer will be used for the quality control evaluation,
future reference, or records. Training and evaluation of
spray and calibration is provided to all operators every 2
months.
Deployment of auto-dissemination devices
Auto-dissemination devices are black plastic containers
that mimic breeding sites for female mosquitoes. ADDs
Fig. 2 Flowchart of cluster selection and allocation, Federal Territory of Kuala Lumpur and Putrajaya
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use In2Mix powder that contain two active ingredients.
The first is technical grade pyriproxyfen (PPF) at doses
of 0.375 g per refill sachet. PPF is an insect growth
regulator (IGR) that prevents mosquito larvae from
developing into adults. The second active ingredient is
spores of the insect specific fungus Beauveria bassiana
GHA strain at 0.05 g per refill sachet. Adult female
mosquitoes that visit the ADD pick up the In2Mix
powder solution from the statically charged netting. The
fungus slowly kills the mosquitoes, while the PPF is
transferred by the mosquito to surrounding breeding
sites (i.e. auto-dissemination), thereby reducing Ae.
aegypti populations by decreasing the emergence of new
adult mosquitoes [15].
The strategy for ADD deployment in these urban
settings was adapted from In2Care standard
recommendation (1 trap/400m2), based on results from
our pilot study in Johor Bahru, Malaysia [21], and
another study evaluating the vertical infestation of Aedes
in high-rise building [22]. Smart deployment of ADDs
only on floors with higher expected mosquito density
was found to be sufficient to reduce the mosquito popu-
lation in the whole building.
The exact number of ADDs and suitable location is
determined at the start of the study (Additional file 2).
ADDs are deployed at the same time as TORS and
distributed over each floor as evenly as possible and
placed according to the manufacturer’s
recommendations in semi-indoor environment such as
corridors, multipurpose halls, lobby, prayer hall, shops,
and parking (i.e. shaded sites).
Community engagement
Community engagement (CE) starts at the time of
baseline data collection and is maintained throughout
the study period by a team specially trained in CE
activities. The main objectives of this activity are to
create public awareness and trust and to increase their
participation during and following the deployment of
the intervention. The first step of CE activities consists
of an appointment with the community leaders in each
cluster through phone calls using a standard script in
order to schedule a face-to-face meeting. The purpose,
objectives, procedure, and timelines of the iDEM trial
are presented to community leaders followed by a
question-and-answer session. Information on demo-
graphic and architectural characteristics such as number
of buildings, number of floors per building, number of
units per floor, total number of occupants, parking lots,
and public facilities (gymnasium, kindergarten, shops,
restaurants, swimming pool, and playground) of the
cluster are recorded after the briefing. A second meeting
involving the residents is organized upon the community
leader request. Information, education, and
communication material such as banners, posters (Add-
itional file 3), and brochures are distributed to explain
the objectives of the study and the role of the commu-
nity during and following the deployment of the inter-
vention. Softcopy of these materials is sent to the
building managers through email or WhatsApp message
and subsequently disseminated among the community.
A notification is sent to the building manager one week
before the deployment of the intervention to remind
them of the date and details about the intervention.
Outcomes
The primary outcome measure is the estimated dengue
incidence rate in both control and treatment clusters.
The number of confirmed dengue cases is provided by
the e-Dengue system (http://spwd.arsm.gov.my).
Dengue is a notifiable disease in Malaysia. All
clinically suspected or confirmed dengue cases are
notified by the medical officer to the nearest District
Health Office within 24 h (Additional file 1). Currently,
dengue confirmation is based on dengue rapid combo
test for (1) qualitative detection and differentiation of
specific IgG and IgM antibodies to dengue virus in
human serum and plasma and (2) dengue rapid NS1 test
for qualitative detection of dengue NS1 antigen in
human whole blood, serum, and plasma [23]. Further
laboratory tests are performed if necessary (under
clinical management not determined by the current
trial). The e-Dengue case definition is based on the
international classification of diseases ICD (10: A90,
A91) and positive diagnostic results of either NS1, IgM,
or IgG or any combination of test results [24]. Since
2014, all cases reported in Malaysia are confirmed cases.
Secondary outcomes measures include:
1) Ovitrap index (OI): number of positive ovitraps
divided by the total number of recovered ovitraps.
2) Larval index (LI): number of larvae identified
divided by the number of ovitraps recovered.
3) Container index (CI): proportion of water-holding
surveyed containers infested with Aedes larvae or
pupae.
4) Adult survey: mean number of female adults Aedes
collected in sticky ovitraps.
5) Resistance to deltamethrin: measurement of knock-
down and mortality rates in wild strain adult mos-
quito population
6) Residual activity of deltamethrin measured by wall
deposit bioassays [25]
Sample size
The sample size determination was adapted from the
bootstrap approach of Kleinman and Huang [26] for
cluster randomized trials. To take into account the
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regression to the mean due to the selection of the
localities with the highest incidence rates in 2015–2016,
sample size determination was based on the incidence
rates of the years 2017–2018. For the purpose of sample
size calculation, the estimated number of inhabitants in
each cluster was obtained as follows: number of blocks
(buildings) x number of floors × number of apartments
in each floor × 4.9 (i.e. estimated number of individuals
in each apartment is based on National Health and
Morbidity Survey 2019 and Department of Statistics).
The mean of the cluster-level incidence rates was 0.34%
per year (range 0 to 4% per year). The power calculation
used resampling with replacement to generate plausible
incidence distributions during the future study period, in
each arm. The resampling was repeated 5000 times.
Each time, the resampled data from the clusters under-
went a simulated randomization to the intervention or
control arm. For those in the control arm, the inferred
dengue incidence rates were calculated from the con-
firmed dengue cases observed during the years 2017–
2018. For clusters in the intervention arm, the inferred
incidence rates were calculated from the observed inci-
dence rates multiplied by the expected effect of the
intervention. The effect of the intervention was esti-
mated from this simulated dataset using a negative bino-
mial regression model. Finally, the power was estimated
as the proportion of analyses with a p value ≤ 0.05 (two-
sided). If we assume that the minimum effect that we
are able to detect is a reduction in the incidence by 33%
in the intervention areas (0.34% and 0.23% estimated
mean incidence rates per year in the control and inter-
vention arms, respectively), the inclusion of 280 eligible
clusters (140 per arm) achieves a power of 85%. This
means that, if the rates are as assumed, the study has
85% probability of establishing a benefit of the interven-
tion, using a two-sided significance level of 5%. This
power was considered acceptable and this sample size
was used for the trial. In order to take into account po-
tential loss of some clusters (refusal to participate,
etc…), 300 clusters were randomized in the two arms
(150 per arm).
Allocation
The random allocation of the clusters to the control or
the intervention arm (1:1 ratio) was carried out using
the PLAN procedure of SAS software, version 9.4
(Copyright (c) 2002-2012 by SAS Institute Inc., Cary,
NC, USA), and was stratified on the economic level of
the clusters (low or medium) because this is associated
with dengue incidence.
In each stratum, clusters were randomly numbered
and block randomization were carried out with block
sizes of 10 and 16 in order to allocate the clusters to the
intervention or control arm. Randomization was carried
out after the protocol was approved by the IMR
Research Committee.
This trial is not blinded. All clusters were allocated at
the start of the trial so an allocation concealment
mechanism is not required. Dengue outbreaks are
common in Malaysia and controlled by reactive vector
control activities. Therefore, discontinuing or modifying
the allocated interventions in case of unexpected dengue
outbreak was not planned. The allocation sequence has
been generated by a statistician of the Service of
Biostatistics of Hospices Civils de Lyon, France. The
code written by this first statistician was double-checked
by a second statistician in regard to the conformity to
the randomization protocol. The list of clusters in each




No active recruitment of dengue cases is planned, as the
information on the incidence of dengue during the
overall study period in both control and intervention
clusters is extracted from the national e-Dengue surveil-
lance database. For each confirmed dengue case, demo-
graphic data, signs and symptoms at first medical visit,
date of diagnosis, results of the rapid dengue COMBO
test, hospitalization, and vital status at discharge are
extracted.
Entomological data
Entomological data for the assessment of secondary
outcomes are collected in 12 clusters randomly selected
from each arm (24 in total) and stratified by socio-
economic status (medium versus low cost).
Climatic parameters
Common climatic parameters (rainfall, temperature, and
humidity) have been reported to influence the intensity
and magnitude of dengue incidence [27–29]. These
parameters will be requested from the Malaysian
Meteorological Department, Ministry of Energy, Science,
Technology, Environment and Climate Change for two
points: Petaling Jaya and Kuala Lumpur International
Airport.
Monitoring Aedes population densities
The density of Aedes aegypti and Ae. albopictus
populations will be monitored monthly throughout the
study period using larval and adult collection methods
in a sample of 12 clusters per arm. Larval surveys are
carried out using a minimum of 40 ovitraps per cluster.
Each ovitrap consists of a 250-ml cylindrical, black plas-
tic container (7.5 cm diameter, 9.0 cm height, 300 ml vol-
ume) filled with tap water to a depth of 5.5 cm and is
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equipped with a removable oviposition paddle made
from a thin strip of brown hardboard (10 cm × 2.5 cm ×
0.3 cm). Larval surveys start 5 weeks before the start of
the intervention to measure the baseline density. Ovi-
traps are positioned randomly in spaces with minimum
human, physical, and environmental disturbance: (a) in
the semi-indoor environment—defined as the area out-
side of the housing units but still sheltered by the roof
(e.g. shared corridor and stairway), (b) in partially or to-
tally shaded outdoor areas (e.g. near bushes, small
plants, and temporary structures), and (c) indoor (under
the sofa, dining table, sink, bed, working / study desk)
only in the apartments of those who volunteer to have
them.
To determine the OI, all ovitraps are collected once a
week and replaced by new ones with fresh tap water and
egg-free oviposition paddles. The collected ovitraps are
brought back to the IMR laboratory (Kuala Lumpur) for
further processing. Ovitrap contents and oviposition
paddles are transferred into plastic containers and la-
belled with the name of the cluster and date of collec-
tion. Larvae emerged from the eggs laid in the ovitraps
undergo species identification [30, 31] using a com-
pound microscope (Nikon Eclipse® E100, Japan).
To determine the CI, a minimum of 20 suspected
mosquito breeding containers within 50 m radius of the
study cluster are examined once a month in each
cluster. Larval samples from the positive containers are
collected in a sample bottle and brought back for
identification. The larvae are allowed to emerge into
adults for morphological identification.
To monitor adult mosquito densities, monthly surveys
are carried out with sticky ovitraps, i.e. a modification of
conventional ovitraps as described by Lau et al [32]. The
inner wall of the ovitrap is lined with a 5.5 cm × 24 cm
transparent plastic sheet. The inner plastic sheet is
covered with insect glue (Neopeace, ACM, Malaysia)
attached to the container using adhesive tape on both
sides of the top of the container. A hole is drilled about
3 cm above the bottom to avoid flooding of the trap
with rain water. A total of 50–200 sticky ovitraps are
deployed in the study area, in every alternate floor with
emphasis on dark and humid areas such as garbage
rooms, emergency exits, shoe racks, and vegetation
considered as Aedes resting places. The adult samples
are isolated in a single vial and send for identification.
Monitoring mosquito resistance
Adult bioassay test
We will measure susceptibility levels to deltamethrin in
the field population. The test will follow the WHO
protocol [33]. Pyrethroid resistance monitoring is
conducted on sugar-fed adult female mosquitoes aged 3
to 5 days against a diagnostic concentration (0.03%
deltamethrin, 0.25% permethrin, 0.15% cyfluthrin, and
0.03% lambda-cyhalothrin), which is used to impregnate
paper at the recommended exposure time. Five repli-
cates of 20 adult field strain mosquitoes from the 24
clusters selected for entomological endpoints are pre-
pared. Two replicates of susceptible mosquitoes from
the insectary laboratory of IMR are used as control
strains. The cumulative knockdown counts are recorded
every minute within the exposure period of 1 h, or until
90% knockdown is observed. After the exposure period,
all the tested mosquitoes (live and knocked down) are
transferred into holding tubes for a 24-h recovery period
and supplied with 10% sugar solution in cotton balls.
Adult mortality is then recorded. If the mortality rate in
the control group is between 5 and 20%, the percentage
of mortality in the exposed mosquitos is corrected by
using Abbot’s formula [33]. Surviving mosquitoes are
transferred into Eppendorf tubes and kept at − 80 °C for
enzyme micro-assay.
Enzyme micro-assay
Three enzyme assays, namely mixed function oxidase
[34, 35], esterase [35, 36], and insensitive
acetylcholinesterase [35] are conducted in sugar-fed fe-
male mosquitoes, aged 3–5 days, to determine the en-
zyme activity. The female mosquitoes are raised from
eggs collected in the field. The same homogenate of an
individual mosquito is used to assess all three enzyme
assays.
Monitoring quality of TORS and ADDs post-application
The quality control monitoring for ORS was conducted
in 4 clusters using a susceptible laboratory strain
mosquito, resistant laboratory strain mosquitoes, and a
wild field strain mosquitoes of Aedes aegypti. To assess
post-application quality of K-Othrine® Polyzone spray,
wall deposit bioassays are conducted 48 h after spraying
and repeated every 3 weeks for a period of 4 months
[25]. Standard WHO bioassay cones are firmly posi-
tioned onto the TORS treated wall in a perpendicular
position using masking tape. Ten adult female mosqui-
toes (sucrose-fed, 3–5 days old, non-blood fed) are intro-
duced into the bioassay cone for 30 min through the
aperture using a battery-operated aspirator, and then
collected back and observed for 24 h mortality. Three
biological replicates of 10 mosquitoes are prepared for
laboratory and field strains of Aedes aegypti. Residual ef-
fect of K-Othrine® Polyzone is determined by evaluating
the knock down time and mortality rate. Knock down is
observed for 30 min at 1-min intervals. After exposure,
the mosquitoes are aspirated out, transferred to paper
cups, held at 27 ± 2 °C with 75 ± 10% relative humidity
and sugar-fed. The mortality is recorded 24 h after
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testing. The level of resistance is evaluated using the
WHO criteria [33].
To assess ADD quality post-application, the presence/
absence and estimated quantities of mosquito larvae in
the water inside the ADDs are recorded at each service.
The water was collected from randomised ADD (3
ADDs) in study sites and tested using laboratory strain
of Aedes aegypti. Every month, 250 ml water samples are
taken from three randomly selected deployed ADDs that
are positive for Aedes larvae and brought back to the la-
boratory to confirm the presence and activity of the pyri-
proxyfen larvicide. In each 250 ml ADD water sample,
25 third instar (L3) larvae from the IMR rearing colony
of Aedes aegypti are added [33]. Emergence of mosquito
adults is monitored every day until all larvae have
emerged or died or all larvae from control emerge into
adult. An emergence rate of adult mosquito less than
10% is indicative of adequate pyriproxyfen quality in the
ADD water sample. The samples are collected at the
same time as the Container Index sampling and are used
for quality control of the ADD and as positive control
for the auto-dissemination testing.
To assess auto-dissemination efficacy of the ADDs,
water samples of nearby containers are assessed for pyri-
proxyfen content. The Aedes-positive samples from nat-
ural containers collected for the CI (as explained above)
are used to monitor larval development. Per 10 ml water
sample collected, one susceptible strain larvae (L3, Aedes
aegypti) is added to the water. Emergence of adults is
monitored every day until all larvae have emerged or
died. Significant reductions in adult mosquito emergence
rates (i.e. high rates of larval/pupal mortality) in the
intervention cluster samples compared to the control
cluster samples is indicative of pyriproxyfen autodisse-
mination from the ADDs.
Data management
Epidemiological data are extracted from the e-Dengue
system by the staff of the Vector Borne Disease Sector,
Disease Control Division, Ministry of Health Malaysia.
Confirmed dengue patients are assigned a unique an-
onymous code. Entomological data are reported on
paper-based forms and subsequently entered into an
Excel file by data managers at IMR. A second data man-
ager checks the accuracy of the Excel file by comparing
the paper-based forms and data entered in the Excel file.
Access to the data is password protected and restricted
to authorized study investigators and data management
staff.
Both epidemiological and entomological data are sent
to the department of Biostatistics in Lyon-France on a
monthly basis. Data are controlled for consistency by the
team in Lyon. The list of inconsistent or erroneous
values (i.e. data queries) is sent to the data managers in
IMR for verification. A database in SAS software is pre-
pared for final statistical analyses. A common identifier
for clusters is used in order to link the entomological
and epidemiological databases.
The original paper-based entomological forms are
stored in secured locked cabinets at IMR. As for epi-
demiological data, access to the data is password pro-
tected and restricted to only authorized study
investigators and data management staff. The anon-
ymized databases sent to the service of Biostatistics of
Hospices Civils de Lyon are stored in the study folder on
a secured computer server. Only the biostatisticians in
charge of the analyses have access to the data. A daily
backup of the study folder is made automatically.
No human samples will be collected for, or held by,
this study. Entomology specimens will be stored at IMR.
This study will be carried out in compliance with the
Malaysian Personal Data Protection Act 2010,
stipulating full protection of an individual’s personal
information.
All data, documents, the database, and the
intervention procedure will be available for audits by
regulatory and independent authorities appointed by
funders or IMR.
Plans to promote participant retention and complete
follow-up
Our previous study showed that regular contacts
between the study population and the field workers
create public trust [21]. To maintain adherence to the
interventions, a liaison officer assigned to each cluster
contacts (via phone call or messaging) the building
manager regularly to collect all complaints and feedback
from the population. The pest control organisation in
charge of TORS and ADDs deployment provides also
regularly feed back to the CE team on any concerns
faced in the field. These are discussed and taken into
consideration in order to improve adherence to the
intervention.
Statistical methods
Statistical analysis will be performed using the statistical
analysis software SAS® version 9.4. or higher. Missing
data will be reported and their impact on the outcomes
may be explored. No interim analyses are planned.
Primary outcome
The primary endpoint is to measure the effectiveness of
the IVM approach on dengue incidence. The mean of
the cluster-level incidence rates will be compared be-
tween the control and intervention arms. In each cluster,
the incidence rate will be estimated as the ratio of the
number of dengue cases registered during the trial
(starting from the first cycle of spraying and ending
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three months after the last spraying cycle), divided by
the number of person-years. The number of inhabitants
per cluster, as obtained for the sample size calculation, is
checked and corrected if needed during the site visits for
the purpose of calculation of incidence rates.
A negative binomial regression model will be used to
compare the incidence between control and intervention
clusters as a final value from the end of the first
intervention cycle. This will yield the rate ratio and its
95% confidence interval, taking into account
overdispersion. The response variable for this analysis
will be the number of cases, and the logarithm of the
person-years will be included as an offset. Stratification
(low versus medium income) will be included as a
covariate.
Secondary outcome
The main secondary outcome will be the OI. The latter
will be estimated over the baseline and intervention
period in the 24 clusters selected for entomological
monitoring. To quantify the effect of the interventions
on the proportion of positive ovitraps, a modified
ordinary least squares regression model using a robust
standard error estimator will be implemented [21].
Using this model, the effect of the interventions will be
quantified by the estimation of a difference of risk with
its 95% confidence interval. This analysis will be carried
out for both species overall and for each of the two
species of mosquito separately.
Larval count per ovitrap (LI) will be estimated in the
24 clusters selected for entomological monitoring over
the baseline and intervention period. A negative
binomial regression will be used with the number of
larvae as the response variable. The analysis will be
adjusted by the baseline measurement of the outcome.
Using this model, the effect of the interventions will be
quantified by the estimation of a ratio of means with its
95% confidence interval. This analysis will be carried out
for both species overall and for each of the two species
of mosquito separately if possible.
The adult population will be estimated by counting
the number of adult female Aedes mosquitoes collected
with sticky ovitraps during the study. The total number
of adult females will be divided by the number of sticky
ovitraps used to obtain the mean number of adult
females.
The emergence rate, defined as the proportion of
larvae that emerge as adult mosquitoes, will be
estimated in each arm and compared between the
two arms using the chi-squared test or the Fisher
exact test. This analysis will be carried out for both
mosquito species combined and for each species
separately.
Methods in analysis to handle protocol non-adherence
and any statistical methods to handle missing data
The main analysis will be by intention to treat. The
clusters will be analysed in their randomization arm. As
explained above, the primary outcome is provided by the
e-Dengue system and will be consequently available for
the overall included clusters during the study period. A
secondary per protocol analysis will be carried out ex-
cluding the clusters with any major deviations to the
protocol. Major deviations will be defined by the tech-
nical committee (trial governance members) during the
data review.
Trial governance
Implementation of the field work is coordinated by IMR
(Malaysia). The Malaysian Ministry of Health provide
technical expertise and is in charge of dengue data
extraction from the e-Dengue database. The Depart-
ments of Epidemiology and Public Health and of Biostat-
istics (Claude Bernard University and Hospices Civils de
Lyon-France) host the project leader and are responsible
for statistical analyses. The trial is governed by a tech-
nical committee composed of academic/private partner-
ship with skills and knowledge in the epidemiology of
infectious disease in particular vector-borne diseases, en-
tomology, new vector control technologies, policy
makers, and statistics. The committee defines the study
design, review available data, and make decisions on trial
conduct.
Adverse event reporting and harms
The product for spraying outdoor walls is already
registered in Malaysia and has been in use for vector
control management. Both bio-actives of ADDs have
short half-lives and are classified as low risk for non-
target organisms. However, instructions about precau-
tionary measures to be taken before and after the inter-
vention are provided in the posters (supplementary
material appendix 2) and during community engagement
meetings. In addition, a dedicated phone number is pro-
vided by the research team to be contacted in the case
of an event which might be linked to the interventions.
We do not plan to set up a data monitoring committee
for the purpose of this cRCT. The trial interventions do
not include drugs. On ethical review in Malaysia, the
study was assessed as no more than minimal risk.
Plans for communicating important protocol
amendments to relevant parties
Any modification in the protocol that significantly
affects the scope or the scientific quality of the
investigation will be submitted to the ethical committee
with an amendment containing a verbatim description
of the changes.
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Dissemination plans
The results of the trial will be disseminated through
international scientific conferences and submitted to
highly ranked peer-reviewed journals for publication.
The findings will also be shared with regional, national,
and international stakeholders and partners. Reporting
will follow the guidelines in the Consolidated Standards
of Reporting Trials (CONSORT) Statement [37].
Authorship will follow guidelines established by the
International Committee of Medical Journal Editors
(http://www.icmje.org/) which require substantive con-
tributions to the design, conduct, interpretation, and
reporting of a trial.
Discussion
In the absence of vaccines and therapeutics, efficient,
sustainable, and cost-effective vector control pro-
grammes are considered the principal method of protec-
tion against vector-borne diseases. New vector control
technologies, prototypes, or products such as spatial re-
pellents, ADDs, sterile insect techniques, and Wolbachia
are currently under investigation by the Vector Control
Advisory Group VCAG-WHO [38]. However, the epi-
demiological evidence of their impact on the incidence
of vector-borne diseases is limited [39].
The iDEM trial aims to address this gap by measuring
the effectiveness of a preventive IVM approach on the
incidence of dengue. The well-known spatial heterogen-
eity of dengue incidence that leads to increased baseline
inter-cluster variance and the inter-annual fluctuation of
dengue epidemic have been taken into consideration
during the study power calculation and by conducting
the study over 2 years respectively. The results of the
trial will provide valuable insights that could be of inter-
est to national and international institutions involved in
the control of dengue.
The vector control tools of the proposed IVM are
relatively new and have been scientifically proven to be
effective against vectors [3, 21, 40]. High bio-efficacy for
K-Othrine® Polyzone used in semi-indoor areas with >
80% mortality for a period of almost 4 months has been
reported in two studies carried out in Malaysia [21, 41].
These results suggest that TORS can potentially reduce
the frequency of current insecticide applications, in par-
ticular in densely populated urban districts where cover-
age of indoor preventive measures is low. ADDs are
currently registered and used in over 45 countries world-
wide and were shown to be effective as auto-
dissemination device under field conditions [21, 40].
The choice of RCT was based on the WHO guideline
that considers this type of trial as level 1 of the hierarchy
of study designs that is sufficiently robust to generate
evidence on the efficacy and public health value of
vector control products [12]. The cluster rather than
individual-based RCT is well adapted to assess
organizational and behavioural interventions, health pro-
motion programs, or interventions that are usually im-
plemented at the level of health organizational units or
geographical areas. Although such design requires large
sample size, it reduces contamination between those
assigned to the intervention or control arm. The large
scale cRCT described in this protocol is unique in its ap-
proach. It combines two relatively new control tools that
complement each other by targeting both larval and
adult stages of the mosquito’s life cycle. Using this com-
bination, the TORS method will potentially reduce the
infective adult mosquito while the ADDs will help to
sustain the mosquito population below the threshold as
described in the Malaysian Ministry of Health guideline
[42]. This is further complemented by extensive public
engagement activities to make the public better aware of
the problems and solutions, encouraging a behavioural
change. This could potentially increase the efficacy of
vector control programmes and decrease dengue
incidence.
The study area is suitable for the proposed trial
because Malaysia is one of the Asian countries hardest
hit by dengue, with all its current 32.6 million
inhabitants at risk. The country has appropriate
infrastructure (expertise in vector control management,
strong social mobilization capacities, and existence of
surveillance systems) that facilitates the successful
implementation of such large-scale trials. The WHO-
IVM approach [13] underlines the importance of
strengthening communication among different health-
care bodies such as policy-makers and vector-borne dis-
ease programme managers for the implementation of
mosquito control strategies. The trial is, therefore, car-
ried out in close collaboration with the Malaysian Minis-
try of Health, enabling local support and continuity of
the proposed IVM approach if promising results are
observed.
The trial is designed to measure the reduction in the
incidence of dengue in the intervention relative to the
control areas using incidence data extracted from the
national e-Dengue surveillance system. Although passive
dengue surveillance in endemic countries is essential for
timely detection and containment of outbreaks, it is sub-
ject to under-ascertainment (cases not being diagnosed)
and under-reporting (cases being diagnosed but not in-
cluded in surveillance data). In Malaysia, failure to re-
port leads to penalties for medical doctors. This is
therefore likely to reduce the under-reporting, in par-
ticular for symptomatic dengue cases. Imperfection of
the dengue diagnosis tests is another concern [43]. The
use of combined IgM and NS1 detection into one test in
Malaysia allows for high sensitivity during both the early
(NS1) and late (IgM) phases of the disease, thus
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improving the overall test performance. Only cases with
positive RDT test and fulfilling the international clinical
criteria (ICD10: A90, A91) are registered in the e-
Dengue surveillance system, thereby improving the spe-
cificity of the system [23].
One possible source of bias is that due to the nature of
the intervention, blinding was not feasible. A feeling of
protection provided by the intervention could potentially
affect health-seeking behaviour in case of a febrile epi-
sode or to a lesser extent to the use of other preventive
measures. The latter reasoning has been suggested as an
explanation in a recent study that evaluated the impact
of insecticide treated curtains on dengue virus transmis-
sion [44]. Another concern is the continued compliance
of participating clusters and their collaboration with the
field workers during the intervention cycles to remove
bulky objects from the corridors at the time of TORS
spraying. Public trust in the Malaysian Ministry of
Health, responsible for routine dengue prevention and
control, and representing the main coordinator of the
present intervention together with continuous dialogue
with the community by providing information about the
programme is expected to alleviate this issue. The rou-
tine vector control activities, which clearly are not being
interrupted, will be monitored. However, these interven-
tions would cause only an underestimation of the true
effect of the proposed IVM strategy, relative to no
action.
Even if efficient in the prevention and control of
dengue, particularly for difficult to treat urban setting, a
vector control programme such as the preventive IVM
approach presented here can be scaled-up as a national
programme if it is cost effective. Analysis of the cost-
effectiveness of the proposed IVM strategy compared to
the routine vector control activities is therefore a key
parameter for its future adaptation as a national vector
control program. Efforts are ongoing to secure the
budget for the economic evaluation of our trial that will
be conducted as an ancillary study of the present
protocol.
In conclusion, a long-term residual effect of K-
Othrine® Polyzone [21, 41], proven efficacy of ADDs
[15, 16, 40], and relatively simple maintenance of
both vector control methods would enable a sustain-
able preventative strategy instead of a responsive vec-
tor control. We expect that co-application of these
vector control tools together with public cooperation
could prove an invaluable vector control approach to
reduce the burden of dengue. By regular communica-
tion with the residents, we hope to create local cap-
abilities by transferring responsibilities (e.g. adding
water to dried ADDs) and promote their participation
(e.g. destruction of breeding sites) in national efforts
to reduce the burden of dengue.
Considering the ongoing expansion of dengue burden
in Malaysia, setting up proactive vector control
strategies are critical. The results will be informative for
a better understanding of effectiveness of proactive IVM
approach in the control of dengue. Evidence from this
trial may help justify investment in preventive IVM
approaches as preferred to reactive case management
strategies. It is conceivable that the result of this trial
could be used in other locations with similar ecology or
adapted to other Aedes borne diseases with same vector
and process of transmission.
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